A phase II trial of riluzole, an antagonist of metabotropic glutamate receptor 1 (GRM1) signaling, in patients with advanced melanoma
| Image |  |
|---|---|
| Description | scientific article published on 17 February 2018 |
| Author/s |
author: Andrew Zloza James S Goydos Jason M Schenkel Janice Mehnert |
| Publication date | February 17, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |